# In Situ Training

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/in-situ-training

- Industry: Internet
- Headquarters: Pessac, France
- Website: www.invivox.com
- Total disclosed funding: $7.9M
- Latest round: Series A (Apr 1, 2022)
- Investors on record: 4

## About

In Situ Training SAS, operating under the brand Invivox, develops digital platforms for medical education, enhancing training and professional development for healthcare practitioners worldwide.Founded in 2015 in Pessac, France, In Situ Training SAS specializes in creating digital platforms for medical training. The company has completed three funding deals, with the latest round being a Series A in April 2022, where it raised EUR 7.147 mn, led by Educapital and MACSF. CEO Julien Delpech co-founded the company alongside Marc Patarin, Nicolas Reffait, Patxi Ospital, and Richard Rohou.Invivox provides an online learning management system focused on medical training and professional development, offering courses, webinars, and workshops. The platform assists healthcare professionals in staying updated with the latest medical techniques, targeting hospitals, medical schools, and individual practitioners across Europe and North America.In the most recent fiscal year, Invivox reported a revenue of EUR 76,071.60 with an EBITDA of EUR -703,986.60.Following its Series A funding round on April 1, 2022, where EUR 7.1 million was raised, In Situ Training SAS plans to utilize the funding to expand its business operations. The company aims to launch new educational products and penetrate additional markets, enhancing its reach in the healthcare education sector.

## Funding rounds

- Series A, Apr 1, 2022, $7.9M — Bpifrance, ISAI, MACSF, Educapital

## Investors

- Bpifrance — Series A
- ISAI (https://capitalatlas.ai/funds/isai) — Series A
- MACSF — Series A
- Educapital (https://capitalatlas.ai/funds/educapital) — Series A